Next Meetings

Amyloidosis

Midwest CEPAC
September 13, 2018 9am- 5pm CT

Chicago Marriott at Medical District/UIC

625 S Ashland Ave

Chicago, IL 60607

The Midwest CEPAC will deliberate and vote on ICER's report on treatments for hereditary transthyretin-related (hATTR) amyloidosis, a rare genetic condition characterized by nerve, heart, and eye damage that is currently treated through supportive measures alone. The Council will also review a report on therapies for prostate cancer during this meeting.

Register

Prostate Cancer

Midwest CEPAC
September 13, 2018 9am-5pm CT

Chicago Marriott at Medical District/UIC

625 S Ashland Ave

Chicago, IL 60607

The Midwest CEPAC will deliberate and vote on evidence presented in ICER's report on anti-androgen drugs for high risk prostate cancer. During this meeting, the Council will also discuss ICER's review of treatments for amyloidosis .

Register

October 25, 2018 10am-4pm PT

California Endowment Oakland Conference Center
2000 Franklin St.
Oakland, CA 94612

CTAF will convene to review ICER's assessment of therapies for hereditary angioedema.


Opioid Use Disorder

New England CEPAC
November 8, 2018 10am - 4pm ET

Newton Marriott
2345 Commonwealth Avenue
Newton, MA 02466

The New England CEPAC will convene to review evidence on medications for addiction treatment in opioid use disorder.


Asthma

Midwest CEPAC
November 29, 2018 10am-4pm CT

Hilton St. Louis Frontenac
1335 S Lindbergh Boulevard
St. Louis, MO 63131


February 21, 2019 10am-4pm PT

Preservation Park (Nile Hall)
668 13th Street, Oakland, CA 94612
Oakland CA, 94612

CTAF will convene to review ICER's assessment of canakinumab for atherosclerosis.


Spinal Muscular Atrophy

New England CEPAC
March 7, 2019 10am-4pm ET

Boston, MA

The New England CEPAC will convene to deliberate and vote on ICER's report on treatments for SMA.


past Meetings